Omega Healthcare Investors (BSP:O2HI34) Cash Flow from Operations: R$4,928 Mil (TTM As of Mar. 2026)


BSP:O2HI34 Omega Healthcare Investors Inc BSP:O2HI34
49 GF Score
Price R$77.02
GF Value R$62.11
Valuation Modestly Overvalued
! 6 Warning Signs
View Full Analysis

What is Omega Healthcare Investors Cash Flow from Operations?

Omega Healthcare Investors BSP:O2HI34 -0.03% 49 Cash Flow from Operations is R$4,928 Mil as of Mar. 2026. GuruFocus rates BSP:O2HI34 with a GF Score™ of 49/100 and a GF Value™ of R$62.11 (Modestly Overvalued). The stock has 6 warning signs investors should review.

Cash flow from operations refers to the cash brought in through a company's normal business operations. It is the cash flow before any investment or financing activities. It is the cash version of net income.

For the three months ended in Mar. 2026, Omega Healthcare Investors's Net Income From Continuing Operations was R$829 Mil. Its Depreciation, Depletion and Amortization was R$440 Mil. Its Change In Working Capital was R$-96 Mil. Its cash flow from deferred tax was R$0 Mil. Its Cash from Discontinued Operating Activities was R$0 Mil. Its Asset Impairment Charge was R$2 Mil. Its Stock Based Compensation was R$55 Mil. And its Cash Flow from Others was R$-103 Mil. In all, Omega Healthcare Investors's Cash Flow from Operations for the three months ended in Mar. 2026 was R$1,127 Mil.


Omega Healthcare Investors  (BSP:O2HI34) Cash Flow from Operations Explanation

For companies reported in indirect method, cash flow from operations contains six items:

1. Net Income From Continuing Operations:
Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Omega Healthcare Investors's net income from continuing operations for the three months ended in Mar. 2026 was R$829 Mil.

2. Depreciation, Depletion and Amortization:
Depreciation is a present expense that accounts for the past cost of an asset that is now providing benefits.
Depletion and amortization are synonyms for depreciation.
Generally:
The term depreciation is used when discussing man made tangible assets
The term depletion is used when discussing natural tangible assets
The term amortization is used when discussing intangible assets

Omega Healthcare Investors's depreciation, depletion and amortization for the three months ended in Mar. 2026 was R$440 Mil.

3. Change In Working Capital:
Working Capital is a measure of a company's short term liquidity or its ability to cover short term liabilities. It is defined as the difference between a company's current assets and current liabilities. Changes in Working Capital is reported in the cash flow statement since it is one of the major ways in which net income can differ from operating cash flow.

Omega Healthcare Investors's change in working capital for the three months ended in Mar. 2026 was R$-96 Mil. It means Omega Healthcare Investors's working capital declined by R$96 Mil from Dec. 2025 to Mar. 2026 .

4. Deferred Tax:
It is the cash flow generated from deferred tax.

Omega Healthcare Investors's cash flow from deferred tax for the three months ended in Mar. 2026 was R$0 Mil.

5. Cash from Discontinued Operating Activities:
Net cash from all of the entity's discontinued operating activities.

Omega Healthcare Investors's cash from discontinued operating Activities for the three months ended in Mar. 2026 was R$0 Mil.

6. Asset Impairment Charge:
It is the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value.

Omega Healthcare Investors's asset impairment charge for the three months ended in Mar. 2026 was R$2 Mil.

7. Stock Based Compensation:
It is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Omega Healthcare Investors's stock based compensation for the three months ended in Mar. 2026 was R$55 Mil.

8. Cash Flow from Others:
These are cash differences caused by the change of inventory, accounts payable, accounts receivable etc. For instance, if a company pays its suppliers slower, its cash position will build up faster. If a company receives payments from its customers slower, its account receivables will rise, and its cash position will grow more slowly (or even shrink).

Omega Healthcare Investors's cash flow from others for the three months ended in Mar. 2026 was R$-103 Mil.


Omega Healthcare Investors Cash Flow from Operations Related Terms


Omega Healthcare Investors Cash Flow from Operations Historical Data

* Premium members only.

The historical data trend for Omega Healthcare Investors's Cash Flow from Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Omega Healthcare Investors Cash Flow from Operations Chart

Omega Healthcare Investors Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cash Flow from Operations
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4,083.61 3,282.19 3,026.78 4,572.27 4,793.11

Omega Healthcare Investors Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cash Flow from Operations Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,047.70 1,326.92 1,215.87 1,258.19 1,126.99
BSP:O2HI34
49GF Score
Omega Healthcare Investors Inc BSP:O2HI34
Cash Flow from Operations is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Omega Healthcare Investors Cash Flow from Operations Calculation

Cash flow from operations refers to the cash brought in through a company's normal business operations. It is the cash flow before any investment or financing activities. It is the cash version of net income.

Omega Healthcare Investors's Cash Flow from Operations for the fiscal year that ended in Dec. 2025 is calculated as:

Omega Healthcare Investors's Cash Flow from Operations for the quarter that ended in Mar. 2026 is:


Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was R$4,928 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Cash Flow from Operations of R$4,928 Mil mean?
Omega Healthcare Investors (BSP:O2HI34) has a Cash Flow from Operations of R$4,928 Mil as of Mar. 2026. Cash Flow from Operations is the amount of cash earned or paid from standard business operations. View historical data for Omega Healthcare Investors and its competitors.
Is Omega Healthcare Investors' Cash Flow from Operations too high?
Omega Healthcare Investors' current Cash Flow from Operations is R$4,928 Mil. Overall, Omega Healthcare Investors has a GF Score™ of 49/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Omega Healthcare Investors' Cash Flow from Operations compare to DOC and AHR?
Omega Healthcare Investors' Cash Flow from Operations of R$4,928 Mil can be compared against companies in the REITs industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Flow from Operations for a REITs company?
A good Cash Flow from Operations depends on the REITs industry context. However, Cash Flow from Operations should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Flow from Operations mean?
A high Cash Flow from Operations can signal that a stock is expensive relative to its fundamentals. Cash Flow from Operations is the amount of cash earned or paid from standard business operations. View historical data for Omega Healthcare Investors and its competitors. Omega Healthcare Investors's current Cash Flow from Operations is R$4,928 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Omega Healthcare Investors stock overvalued right now?
Based on GuruFocus' analysis, Omega Healthcare Investors (BSP:O2HI34) is currently considered Modestly Overvalued. The stock's GF Value™ is R$62.11, compared to a current price of R$77.02 — trading 24% above its estimated fair value. The current Cash Flow from Operations is R$4,928 Mil. Omega Healthcare Investors' overall GF Score™ is 49/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Flow from Operations calculated?
Cash Flow from Operations is calculated from a company's financial statements. For Omega Healthcare Investors (BSP:O2HI34), the current Cash Flow from Operations is R$4,928 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Omega Healthcare Investors (BSP:O2HI34) Overvalued in 2026?

Based on GuruFocus' analysis, Omega Healthcare Investors stock appears to be overvalued. The current stock price of R$77.02 is trading 24% above its estimated GF Value™ of R$62.11. GuruFocus considers Omega Healthcare Investors to be Modestly Overvalued.

Key valuation signals for BSP:O2HI34:

  • Cash Flow from Operations: R$4,928 Mil
  • GF Value™: R$62.11 vs. price of R$77.02 (24% above fair value)
  • GF Score™: 49/100 with 6 warning signs

No single metric tells the full story. See the BSP:O2HI34 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Omega Healthcare Investors Business Description

Industry Real EstateREITs
Address 303 International Circle, Suite 200, Hunt Valley, MD, USA, 21030
Omega Healthcare Investors Inc is a real estate investment trust that invests in healthcare-related real estate properties located in the United States (U.S.), the United Kingdom (U.K.), and Canada. The company's objective is to provide attractive returns to investors while serving as the preferred capital partner to its third-party healthcare operating companies and affiliates, as well as other third-party healthcare operators, allowing them to focus on delivering a high level of care to their resident patients. Omega's investment portfolio mainly consists of skilled nursing facilities, assisted living facilities (ALFs), including care homes in the U.K., independent living facilities, rehabilitation and acute care facilities, and continuing care retirement communities.
49GF Score

Get the complete analysis for BSP:O2HI34

Cash Flow from Operations is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R$77.02
Price
R$62.11
GF Value